Project Details
| Short title | XL092-304 |
|---|---|
| Status | Active |
| Effective start/end date | 4/12/23 → 3/12/28 |
CTU: A Randomized Open-Label Phase 3 Study of XL092 +Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
- Gurney, Howard (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Contacos, Christine (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
Project: Research